Spain · Delayed Price · Currency is EUR BME:ANE Statistics
Total Valuation
BME:ANE has a market cap or net worth of EUR 6.84 billion. The enterprise value is 11.85 billion.
| Market Cap | 6.84B |
| Enterprise Value | 11.85B |
Important Dates
The next confirmed earnings date is Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:ANE has 324.61 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 324.61M |
| Shares Outstanding | 324.61M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.68% |
| Float | 28.73M |
Valuation Ratios
The trailing PE ratio is 10.54 and the forward PE ratio is 28.56.
| PE Ratio | 10.54 |
| Forward PE | 28.56 |
| PS Ratio | 1.67 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 17.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.84, with an EV/FCF ratio of -19.88.
| EV / Earnings | 18.09 |
| EV / Sales | 2.89 |
| EV / EBITDA | 7.84 |
| EV / EBIT | 12.09 |
| EV / FCF | -19.88 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.27 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 3.39 |
| Debt / FCF | -8.59 |
| Interest Coverage | 6.17 |
Financial Efficiency
Return on equity (ROE) is 11.14% and return on invested capital (ROIC) is 5.35%.
| Return on Equity (ROE) | 11.14% |
| Return on Assets (ROA) | 3.96% |
| Return on Invested Capital (ROIC) | 5.35% |
| Return on Capital Employed (ROCE) | 7.59% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 1.31M |
| Profits Per Employee | 208,998 |
| Employee Count | 3,134 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 8.25 |
Taxes
In the past 12 months, BME:ANE has paid 43.00 million in taxes.
| Income Tax | 43.00M |
| Effective Tax Rate | 5.85% |
Stock Price Statistics
The stock price has increased by +20.91% in the last 52 weeks. The beta is 0.52, so BME:ANE's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +20.91% |
| 50-Day Moving Average | 21.15 |
| 200-Day Moving Average | 22.31 |
| Relative Strength Index (RSI) | 52.12 |
| Average Volume (20 Days) | 301,309 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ANE had revenue of EUR 4.11 billion and earned 655.00 million in profits. Earnings per share was 2.00.
| Revenue | 4.11B |
| Gross Profit | 2.43B |
| Operating Income | 981.00M |
| Pretax Income | 735.00M |
| Net Income | 655.00M |
| EBITDA | 1.48B |
| EBIT | 981.00M |
| Earnings Per Share (EPS) | 2.00 |
Balance Sheet
The company has 465.00 million in cash and 5.12 billion in debt, with a net cash position of -4.66 billion or -14.34 per share.
| Cash & Cash Equivalents | 465.00M |
| Total Debt | 5.12B |
| Net Cash | -4.66B |
| Net Cash Per Share | -14.34 |
| Equity (Book Value) | 6.18B |
| Book Value Per Share | 17.98 |
| Working Capital | 478.00M |
Cash Flow
In the last 12 months, operating cash flow was 383.00 million and capital expenditures -979.00 million, giving a free cash flow of -596.00 million.
| Operating Cash Flow | 383.00M |
| Capital Expenditures | -979.00M |
| Depreciation & Amortization | 560.00M |
| Net Borrowing | -675.00M |
| Free Cash Flow | -596.00M |
| FCF Per Share | -1.84 |
Margins
Gross margin is 59.20%, with operating and profit margins of 23.90% and 15.96%.
| Gross Margin | 59.20% |
| Operating Margin | 23.90% |
| Pretax Margin | 17.90% |
| Profit Margin | 15.96% |
| EBITDA Margin | 36.08% |
| EBIT Margin | 23.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | -9.65% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.83% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 9.57% |
| FCF Yield | -8.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |